Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Inari Medical: Q1 Earnings Insights

Inari Medical (NASDAQ:NARI) reported its Q1 earnings results on Wednesday, May 3, 2023 at 04:01 PM. Here’s what…
byBenzinga Insights
May 3, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Inari Medical (NASDAQ:NARI) reported its Q1 earnings results on Wednesday, May 3, 2023 at 04:01 PM.

Here’s what investors need to know about the announcement.

Earnings

Inari Medical beat estimated earnings by 82.61%, reporting an EPS of $-0.04 versus an estimate of $-0.23.

Revenue was up $29.41 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.06 which was followed by a 1.92% drop in the share price the next day.

Here’s a look at Inari Medical’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.17 -0.25 -0.23 -0.09
EPS Actual -0.11 -0.19 -0.19 -0.06
Revenue Estimate 104.84M 90.40M 87.80M 83.61M
Revenue Actual 107.77M 96.20M 92.74M 86.75M

To track all earnings releases for Inari Medical visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Canopy Growth Reports 7% YoY Drop In Q3 Revenue, CEO Touts ‘New Era’ For Company As It Seeks US Listing

By Jelena Martinovic
February 9, 10:20 AM
Canopy Growth reported an 81% YoY increase in "rest-of-world" cannabis revenue for Q3 2024. The company attributed the growth to strong performance in Australia and a return to growth in Europe. Canopy also announced its plans for the US cannabis market through its non-controlling interest in Canopy USA. The company expects to file its definitive proxy statement with the SEC on or about 13 February, followed by a special meeting with shareholders on 12 April. During the meeting, shareholders will consider the creation of a new class of non-voting, non-participating exchangeable shares. Once exchangeable shares are created and Canopy USA acquires US THC businesses, investors are expected to have an opportunity to participate in the US cannabis market.

CGC